Iodine treatment in vitreous degeneration
Raczyńska, K.; Kokot, W.; Krajka-Lauer, J.ła.; Iwaszkiewicz-Bilikiewicz, B.
Klinika Oczna 106(3 Suppl): 517-520
2004
ISSN/ISBN: 0023-2157 PMID: 15636254 Document Number: 568341
We present our result of topical administration of iodine in group of patients with corpus vitreous degeneration. Corpus vitreous degeneration was studied in 360 patients (660 eyes), 184 male and 176 female. Treatment last form 6 to 12 month. We administrate iodine 3-4 times a day as an eye drops. The untreated control group consist of 110 person (204 eyes) 80 male and 50 female with similar corpus vitreous degeneration. The results are discussed in relation to our own vitreous degeneration scale. We come to a conclusion that topical administration of iodine reduce corpus vitreous degeneration.